The Patent Finder

Pemetrexed Formulations

Eagle Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 16/297,125, filed Mar 8, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,793,813Pemetrexed Formulations
In force
 · Low confidence
Eagle Pharmaceuticals, Inc.In force
Low confidence
US 12,115,164Pemetrexed Formulations
In force
 · Medium confidence
Eagle Pharmaceuticals, Inc.In force
Medium confidence
Application 15/048,416Pemetrexed Formulations
Abandoned
Abandoned Dec 11, 2017
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Dec 11, 2017
Application 15/828,858Pemetrexed Formulations
Abandoned
Abandoned Apr 25, 2019
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Apr 25, 2019
Application 16/297,125Pemetrexed Formulations
Abandoned
Abandoned Apr 2, 2024
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Apr 2, 2024
Application 17/898,558Pemetrexed Formulations
Abandoned
Abandoned Oct 20, 2023
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Oct 20, 2023
Application 17/898,637Pemetrexed Formulations
Abandoned
Abandoned Nov 20, 2023
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Nov 20, 2023
Application 17/898,984Pemetrexed Formulations
Abandoned
Abandoned Oct 20, 2023
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Oct 20, 2023
Application 18/236,480Pemetrexed Formulations
Abandoned
Abandoned Oct 31, 2023
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Oct 31, 2023
Application 18/456,772Pemetrexed Formulations
Pending
Not granted
Eagle Pharmaceuticals, Inc.PendingNot granted
1 more patent in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
2 of these are in force and held by Eagle Pharmaceuticals, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited